التداخل بين باراسيتامول وكودايين وكيتامين
باراسيتامول وكودايين وكيتامين: كلتا نشرتَي الوصف تنبّهان إلى هذا الجمع بأشد العبارات، مثل مانع استعمال أو تحذير مؤطر أو تعليمات بتجنّبه.
لا تجمع بينهما دون توجيه من الطبيب الواصف. عبارات النشرة الواردة أدناه هي أشد ما تستخدمه FDA.
ما تقوله نشرات FDA
من نشرة كيتامين (Ketalar) · تاريخ السريان 2026-03-27
Benzodiazepines, Opioid Analgesics, or other CNS Depressants : Concomitant use may result in profound sedation, respiratory depression, coma, or death.
Benzodiazepines, Opioid Analgesics, or Other CNS Depressants Concomitant use of ketamine with opioid analgesics, benzodiazepines, or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death [see Drug Interactions ( 7.3 )] .
Closely monitor neurological status and respiratory parameters, including respiratory rate and pulse oximetry, when KETALR and opioid analgesics, benzodiazepines, or other CNS depressants are co-administered.
Concomitant use of opioid analgesics may prolong recovery time.
Benzodiazepines, Opioid Analgesics, Or Other CNS Depressants Concomitant use of ketamine with opioid analgesics, benzodiazepines, or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death [see Warnings and Precautions ( 5.9 )] .
من نشرة باراسيتامول وكودايين (ACETAMINOPHEN AND CODEINE PHOSPHATE) · تاريخ السريان 2026-01-22
Risks from Concomitant Use with Benzodiazepines or Other CNS Depressants Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death.
Reserve concomitant prescribing of acetaminophen and codeine phosphate tablets and benzodiazepines or other CNS depressants for use in patients for whom alternative treatment options are inadequate ( see PRECAUTIONS, Drug Interactions ).
Screen patients for risk of substance use disorders, including opioid abuse and misuse, and warn them of the risk for overdose and death associated with the use of additional CNS depressants including alcohol and illicit drugs ( see PRECAUTIONS, Drug Interactions and Information for Patients/Caregivers ).
Discuss the importance of having access to an opioid overdose reversal agent, especially if the patient has risk factors for overdose (e.g., concomitant use of CNS depressants, a history of opioid use disorder, or prior opioid overdose) or if there are household members (including children) or other close contacts at risk for accidental ingestion or opioid overdose.
…depression, coma, and death may result from the concomitant use of acetaminophen and codeine phosphate tablets with benzodiazepines and/or other CNS depressants, including alcohol [e.g., non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids (gabapentin or pregabalin), other opioids].
هل تتناول أكثر من هذين الاثنين؟ التداخلات تتراكم. افحص قائمتك كاملة دفعة واحدة؛ وهي تبقى في متصفحك.
افتح في الفاحصليست نصيحة طبية. يقتبس Interaction Checker نص نشرات FDA وصحائف الوقائع الصادرة عن NIH. وأهمية التداخل في حالتك تتوقف على الجرعات والتوقيت ووظائف الكلى والكبد والحالات الصحية الأخرى. تأكّد من ذلك مع صيدلي أو مع الطبيب الواصف.